How Much Did Mission Bio Raise?
Funding & Key Investors

Mission Bio, a significant player in the biotechnology sector, has secured substantial enterprise-level funding, with its total capital raised standing at $117M and its most recent investment round bringing in $0. This financing underscores the company's pivotal role in advancing single-cell multi-omics solutions.

What is Mission Bio?

Mission Bio
Business ServicesResearch & DevelopmentManufacturing

Mission Bio is a biotechnology firm at the forefront of single-cell multi-omics analysis. The company's innovative platform empowers researchers to simultaneously examine DNA, RNA, and protein expression at the individual cell level. This capability is crucial for accelerating breakthroughs in complex fields such as cancer research and the development of novel cell and gene therapies, providing unprecedented insights into cellular heterogeneity and function.

How much funding has Mission Bio raised?

Mission Bio has raised a total of $117M across 5 funding rounds:

2015

Other Financing Round

$1M

2017

Other Financing Round

$6M

Series A

$10M

2018

Series B

$30M

2020

Series C

$70M

Other Financing Round (2015): $1M with participation from Tech Coast Angels

Other Financing Round (2017): $6M led by Keiretsu Forum

Series A (2017): $10M supported by Mayfield, Foothill Ventures, and Tapestri

Series B (2018): $30M featuring Agilent Technologies Cota Capital

Series C (2020): $70M backed by Mayfield, Novo Growth, Agilent, Soleus Capital, and Cota

Key Investors in Mission Bio

Mayfield

Mayfield is a venture capital firm specializing in early-stage technology companies, focusing on enterprise, consumer, and infrastructure sectors, providing support through growth and exit phases.

Keiretsu Forum

Keiretsu Forum is a global network of angel investors and venture capitalists dedicated to funding early-stage companies across various industries.

Agilent Technologies Cota Capital

Agilent Technologies Cota Capital represents a significant backing, indicating strategic interest in Mission Bio's technological advancements within the life sciences sector.

What's next for Mission Bio?

With its latest major enterprise-level funding, Mission Bio is poised to further enhance its technological capabilities and expand its market reach. The strategic investment will likely fuel continued research and development, enabling the company to refine its multi-omics solutions and support a broader range of therapeutic applications. Expect Mission Bio to solidify its position as a leader in single-cell analysis, driving innovation in precision medicine and biopharmaceutical development.

See full Mission Bio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject ManagementHolding Companies & Conglomerates
Business ServicesField Service Management
Business ServicesSoftware Testing
Business ServicesDebt Collection

Frequently Asked Questions Regarding Mission Bio Financial Insights

What are the most recent funding rounds that Mission Bio has completed, and what were the funding rounds?
Mission Bio has recently completed 3 funding rounds: Series C on Aug 13, 2020, Series B on Dec 11, 2018, Series A on Oct 23, 2017.
What is the total amount of funding Mission Bio has raised to date?
Mission Bio has raised a total of $117M in funding to date.
How many funding rounds has Mission Bio completed?
Mission Bio has completed 3 funding rounds.
How much funding did Mission Bio raise in its most recent funding round?
Mission Bio raised $70M in its most recent funding round.
Who are the lead investors in Mission Bio's latest funding round?
The lead investor in Mission Bio's latest funding round was Mayfield. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Mission Bio's history?
The largest funding round in Mission Bio's history was $70M.
See more information about Mission Bio